Percutaneous Mechanical Circulatory Support Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Intra-Aortic Balloon Pumps, VA-Extracorporeal Membrane Oxygenators (ECMO), and Short-Term Ventricular Assist Devices); End User (Hospitals, Ambulatory Surgical Centers, and Others); and Geography

The percutaneous mechanical circulatory support devices market was valued at US$ 1,474.28 million in 2019 and is projected to reach US$ 3,964.75 million by 2027; it is expected to grow a ta CAGR of 13.5% during 2020–2027.

Percutaneous mechanical circulatory support devices offers an effective and rapid approach to slow the downward spiral of hemodynamic instability among patients suffering with decompensated heart failures and cardiogenic shocks till a more definitive strategy is perceived among patients to recover from these cardiac ailments. The major roles of the percutaneous mechanical circulatory support devices includeimproving the native cardiac output, reducing ventricular volume and filling pressures, augmenting coronary perfusion, and maintaining vital organ perfusion.

Market Insights
Rising Geriatric Population

The high market growth is anticipated on account of the rising global geriatric population. In both male and female population, the risk of cardiovascular diseases increases with an increase in age. Aging blood vessels are less flexible,leading to reducedblood flow. Thus, the risk of heart disease is high in the elderly population. Also, according to the Heart Disease and Stroke Statistics 2018, the average age at the first heart attack is 65.6 years for males and 72.0 years for females. It also mentioned that the annual incidence of a heart attack in the US is 720,000 new attacks and 335,000 recurrent attacks. Moreover, according to the National Institutes of Health (NIH), America’s 65-and-over population is projected to nearly double over the next three decades, from 48 million to 88 million by 2050. Cardiovascular disease (CVD) in older Americans imposes a huge burden in terms of mortality, morbidity, disability, functional decline, and healthcare costs. A retrospective study performed by the University of Pittsburgh in 2015 states that the prevalence of CVD, including hypertension, CHD, HF, and stroke, increases from about 40% in men and women 40–59 years and 70-75% in persons aged 60–79 years, and 79–86% among those aged 80 years or older. Thus, the growing geriatric population leading to higher risks of heart failures and cardiogenic shocks increases the applications of percutaneous mechanical circulatory support devices and eventually favors market growth.

Product-Based Market Insights

The product segment of the percutaneous mechanical circulatory support devices market is segmented into intra-aortic balloon pumps, VA-extracorporeal membrane oxygenation, and short-term ventricular assist devices. The intra-aortic balloon pumps segment held the largest share of the percutaneous mechanical circulatory support devices market in 2019. The short-term ventricular assist devices segment is anticipated to grow at aCAGR of 14.0% during the forecast period.

EndUser-Based MarketInsights

The end user segment of the percutaneous mechanical circulatory support devices market is segmented hospitals, ambulatory surgical centers, and others. The hospitals segment heldthe largest shareof the percutaneous mechanical circulatory support devices market in 2019. The segment is also anticipated to grow at a CAGR of 14.2% during the forecast period.

Product launchesand product approvalstrategiesarecommonly adopted by companies to expand their footprintsand product portfolio worldwide and meet the growing demand.

Additionally, the market players operating in the percutaneous mechanical circulatory support devices marketadopt the strategy ofexpansion to enlarge customer base across the world, which permits the players to maintain their brand name globally. For instance, in June 2016, Medetronic launched a product—Beacon, a care management service for high-risk heart failure patients. This service combines data from Medtronic implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) devices with post-acute monitoring from MCMS.

Percutaneous Mechanical Circulatory Support Devices Market Regional Insights

The regional trends and factors influencing the Percutaneous Mechanical Circulatory Support Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Percutaneous Mechanical Circulatory Support Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Percutaneous Mechanical Circulatory Support Devices Market Report Scope

Percutaneous Mechanical Circulatory Support Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Percutaneous Mechanical Circulatory Support Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Percutaneous Mechanical Circulatory Support Devices Market are:

1. Abbott.
2. Medtronic
3. Getinge AB
4. Teleflex Incorporated
5. Livanova Plc (Cardiacassist, Inc.).

Disclaimer: The companies listed above are not ranked in any particular order.

Global Percutaneous Mechanical Circulatory Support Devices Market – ByProduct

• Intra-Aortic Balloon Pumps
• VA-Extracorporeal Membrane Oxygenation (ECMO)
  • Oxygenators
• Short-Term Ventricular Assist Devices (VADs)
  • Impella
  • Tandem Heart

Global Percutaneous Mechanical Circulatory Support DevicesMarket – By EndUser

• Hospitals
• Ambulatory Surgical Centers
• Others

Global Percutaneous Mechanical Circulatory Support Devices– By Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC

• Middle East &Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

• South America (SAM)

  • Brazil
  • Argentina
  • Rest of SAM

Company Profiles

• Abbott.
• Medtronic
• Getinge AB
• Teleflex Incorporated
• LivanovaPlc (Cardiacassist, Inc.).
• Abiomed
• Eurosets
• Berlin Heart
• Jarvik Heart, Inc.
• CardioBridge GmbH

The List of Companies - Percutaneous Mechanical Circulatory Support Devices Market

1. Abbott.
2. Medtronic
3. Getinge AB
4. Teleflex Incorporated
5. Livanova  Plc (Cardiacassist, Inc.).
6. Abiomed
7. Eurosets
8. Berlin Heart
9. Jarvik Heart, Inc.
10. CardioBridge GmbH

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the percutaneous mechanical circulatory support devices  market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global percutaneous mechanical circulatory support devices  market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.